Literature DB >> 18713991

Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Kazuyuki Kawamura1, Katherine A McLaughlin, Robert Weissert, Thomas G Forsthuber.   

Abstract

Genes of the MHC show the strongest genetic association with multiple sclerosis (MS), but the underlying mechanisms have remained unresolved. In this study, we asked whether the MS-associated MHC class II molecules, HLA-DRB1*1501, HLA-DRB5*0101, and HLA-DRB1*0401, contribute to autoimmune CNS demyelination by promoting pathogenic T cell responses to human myelin basic protein (hMBP), using three transgenic (Tg) mouse lines expressing these MHC molecules. Unexpectedly, profound T cell tolerance to the high-affinity MHC-binding hMBP82-100 epitope was observed in all Tg mouse lines. T cell tolerance to hMBP82-100 was abolished upon back-crossing the HLA-DR Tg mice to MBP-deficient mice. In contrast, T cell tolerance was incomplete for low-affinity MHC-binding hMBP epitopes. Furthermore, hMBP82-100-specific type B T cells escaped tolerance in HLA-DRB5*0101 Tg mice. Importantly, T cells specific for low-affinity MHC-binding hMBP epitopes and hMBP82-100-specific type B T cells were highly encephalitogenic. Collectively, the results show that MS-associated MHC class II molecules are highly efficient at inducing T cell tolerance to high-affinity MHC-binding epitope, whereas autoreactive T cells specific for the low-affinity MHC-binding epitopes and type B T cells can escape the induction of T cell tolerance and may promote MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713991      PMCID: PMC2724067          DOI: 10.4049/jimmunol.181.5.3202

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance.

Authors:  Sarah E Cabbage; Eric S Huseby; Blythe D Sather; Thea Brabb; Denny Liggitt; Joan Goverman
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis.

Authors:  M G Marrosu; F Muntoni; M R Murru; G Spinicci; M P Pischedda; F Goddi; P Cossu; M Pirastu
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

Review 3.  The T lymphocyte in experimental allergic encephalomyelitis.

Authors:  S S Zamvil; L Steinman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans.

Authors:  A Kurdi; I Ayesh; A Abdallat; U Maayta
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

5.  T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.

Authors:  K Ota; M Matsui; E L Milford; G A Mackin; H L Weiner; D A Hafler
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

6.  Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.

Authors:  Yili Li; Yuping Huang; Jessica Lue; Jacqueline A Quandt; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

7.  The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families.

Authors:  J Hillert; T Käll; M Vrethem; S Fredrikson; M Ohlson; O Olerup
Journal:  J Neuroimmunol       Date:  1994-02       Impact factor: 3.478

8.  Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice.

Authors:  A Roach; N Takahashi; D Pravtcheva; F Ruddle; L Hood
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

Review 9.  Immunological aspects of demyelinating diseases.

Authors:  R Martin; H F McFarland; D E McFarlin
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

10.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Authors:  A Valli; A Sette; L Kappos; C Oseroff; J Sidney; G Miescher; M Hochberger; E D Albert; L Adorini
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more
  15 in total

1.  Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.

Authors:  Gregory F Wu; Kenneth S Shindler; Eric J Allenspach; Tom L Stephen; Hannah L Thomas; Robert J Mikesell; Anne H Cross; Terri M Laufer
Journal:  J Autoimmun       Date:  2010-11-20       Impact factor: 7.094

2.  Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.

Authors:  Niannian Ji; Animesh Somanaboeina; Aakanksha Dixit; Kazuyuki Kawamura; Neil J Hayward; Christopher Self; Gary L Olson; Thomas G Forsthuber
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

Review 3.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

4.  TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.

Authors:  Itay Raphael; Francisco Gomez-Rivera; Rebecca A Raphael; Rachel R Robinson; Saisha Nalawade; Thomas G Forsthuber
Journal:  JCI Insight       Date:  2019-12-19

5.  Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.

Authors:  Saisha A Nalawade; Niannian Ji; Itay Raphael; Andrew Pratt; Ellen Kraig; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-05-14       Impact factor: 4.868

6.  Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.

Authors:  Jacqueline A Quandt; Jaebong Huh; Mirza Baig; Karen Yao; Naoko Ito; Mark Bryant; Kazuyuki Kawamura; Clemencia Pinilla; Henry F McFarland; Roland Martin; Kouichi Ito
Journal:  J Immunol       Date:  2012-08-10       Impact factor: 5.422

7.  Picornavirus infection leading to immunosuppression.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2014-05-01       Impact factor: 1.831

8.  Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.

Authors:  Itay Raphael; Johanna Webb; Francisco Gomez-Rivera; Carol A Chase Huizar; Rishein Gupta; Bernard P Arulanandam; Yufeng Wang; William E Haskins; Thomas G Forsthuber
Journal:  Front Immunol       Date:  2017-07-17       Impact factor: 7.561

Review 9.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

10.  Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.

Authors:  Jane Falconer; Rahul Mahida; Divya Venkatesh; Jeffrey Pearson; John H Robinson
Journal:  Immunology       Date:  2015-12-21       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.